Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024.
Euro Surveill
; 29(31)2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-39092529
ABSTRACT
As other European countries, France is experiencing a resurgence of pertussis in 2024. Between 1 January and 31 May 2024, 5,616 (24.9%) positive Bordetella pertussis qPCR tests were identified, following a 3-year period of almost null incidence. Of 67 cultured and whole genome sequenced B. pertussis isolates, 66 produced pertactin and 56 produced FIM2, in contrast to pre-COVID-19 years. One isolate of genotype Bp-AgST4 was resistant to macrolides. Pertussis resurgence may favour isolates that produce FIM2 and pertactin.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Bordetella pertussis
/
Tos Ferina
/
Macrólidos
/
Antibacterianos
Límite:
Adult
/
Child
/
Child, preschool
/
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Euro Surveill
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2024
Tipo del documento:
Article